GB0113231D0 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- GB0113231D0 GB0113231D0 GBGB0113231.5A GB0113231A GB0113231D0 GB 0113231 D0 GB0113231 D0 GB 0113231D0 GB 0113231 A GB0113231 A GB 0113231A GB 0113231 D0 GB0113231 D0 GB 0113231D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
Priority Applications (29)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0113231.5A GB0113231D0 (en) | 2001-05-31 | 2001-05-31 | Chemical compounds |
| MYPI20021973A MY132656A (en) | 2001-05-31 | 2002-05-29 | Oxazol/thiazol-derivatives activators of the hppar-alpha receptor |
| KR1020037015678A KR100859591B1 (ko) | 2001-05-31 | 2002-05-29 | Ｈｐｐａｒ-알파 수용체의 옥사졸/티아졸-유도체 활성제 |
| DK02747331T DK1399430T3 (da) | 2001-05-31 | 2002-05-29 | Oxazol/thiazolderivataktivatorer af HPPAR-alfa-receptoren |
| AU2002317765A AU2002317765B2 (en) | 2001-05-31 | 2002-05-29 | Oxazol/ thiazol-derivatives activators of the hPPAR-alpha receptor |
| SI200230654T SI1399430T1 (sl) | 2001-05-31 | 2002-05-29 | Oksazolni/tiazolni derivati kot aktivatorji hPPAR-alfa receptorja |
| HK04106944.0A HK1064367B (en) | 2001-05-31 | 2002-05-29 | Oxazol/thiazol-derivatives activators of the hppar-alpha receptor |
| CZ20033252A CZ20033252A3 (en) | 2001-05-31 | 2002-05-29 | Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor |
| CA002448205A CA2448205A1 (en) | 2001-05-31 | 2002-05-29 | Oxazol/thiazol-derivatives activators of the hppar-alpha receptor |
| BR0209785-0A BR0209785A (pt) | 2001-05-31 | 2002-05-29 | Composto e seus sais, solvatos e ésteres hidrolisáveis farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar alfa em um paciente |
| NZ529754A NZ529754A (en) | 2001-05-31 | 2002-05-29 | Oxazol/ thiazol-derivatives activators of the hPPAR- alpha receptor |
| MXPA03011032A MXPA03011032A (es) | 2001-05-31 | 2002-05-29 | Activadores de derivados de oxazol/tiazol del receptor hppar-alfa. |
| CNB028149424A CN1307166C (zh) | 2001-05-31 | 2002-05-29 | HPPAR－α受体的噁唑/噻唑衍生物活化剂 |
| US10/478,936 US7157479B2 (en) | 2001-05-31 | 2002-05-29 | Oxazol/thiazol-derivatives activators of the hPPAR-alpha receptor |
| JP2003500074A JP2004532267A (ja) | 2001-05-31 | 2002-05-29 | ｈＰＰＡＲα受容体のオキサゾール／チアゾール誘導体アクチベーター |
| ARP020101999A AR034051A1 (es) | 2001-05-31 | 2002-05-29 | Compuesto de oxazol o tiazol, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion |
| IL15892902A IL158929A0 (en) | 2001-05-31 | 2002-05-29 | Oxazol/thiazol derivatives as activators of the hppar-alpha receptor |
| DE60223805T DE60223805T2 (de) | 2001-05-31 | 2002-05-29 | Oxazol/thiazol-derivate als aktivatoren des hppar-alpha-rezeptors |
| TW091111392A TWI245760B (en) | 2001-05-31 | 2002-05-29 | Chemical compounds that activate the alpha subtype of the human peroxisome proliferators activated receptor (hPPAR alpha) and pharmaceutical compositions comprising them for treating hPPAR alpha mediated diseases or conditions |
| EP02747331A EP1399430B1 (en) | 2001-05-31 | 2002-05-29 | Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor |
| PCT/EP2002/005886 WO2002096895A1 (en) | 2001-05-31 | 2002-05-29 | Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor |
| HU0400043A HUP0400043A3 (en) | 2001-05-31 | 2002-05-29 | Oxazol/thiazol-derivatives activators of the hppar-alpha receptor and pharmaceutical compositions containing them |
| PT02747331T PT1399430E (pt) | 2001-05-31 | 2002-05-29 | Derivados de oxazole/tiazole activadores do receptor do hppar alfa |
| PL02367248A PL367248A1 (en) | 2001-05-31 | 2002-05-29 | Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor |
| ES02747331T ES2296965T3 (es) | 2001-05-31 | 2002-05-29 | Derivados de oxazol/tiazol como activadores del receptor pparh-alfa. |
| ZA200309095A ZA200309095B (en) | 2001-05-31 | 2003-11-21 | Oxazole/thiazol-derivatives activators of the hPPAR-alpha receptor. |
| NO20035209A NO20035209L (no) | 2001-05-31 | 2003-11-24 | Oksazol/Tiazol-derivataktivatorer av HPPAR-alfa reseptoren samt anvendelse derav og farmasoytisk preparat |
| CO03106490A CO5540297A2 (es) | 2001-05-31 | 2003-12-03 | Derivados de oxazol/tiazol activadores del receptor hppar- alfa |
| CY20081100202T CY1107206T1 (el) | 2001-05-31 | 2008-02-19 | Παραγωγα οξαζολιου/θειαζολιου ενεργοποιητες του υποδοχεα hppar-a |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0113231.5A GB0113231D0 (en) | 2001-05-31 | 2001-05-31 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0113231D0 true GB0113231D0 (en) | 2001-07-25 |
Family
ID=9915636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0113231.5A Ceased GB0113231D0 (en) | 2001-05-31 | 2001-05-31 | Chemical compounds |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7157479B2 (https=) |
| EP (1) | EP1399430B1 (https=) |
| JP (1) | JP2004532267A (https=) |
| KR (1) | KR100859591B1 (https=) |
| CN (1) | CN1307166C (https=) |
| AR (1) | AR034051A1 (https=) |
| AU (1) | AU2002317765B2 (https=) |
| BR (1) | BR0209785A (https=) |
| CA (1) | CA2448205A1 (https=) |
| CO (1) | CO5540297A2 (https=) |
| CY (1) | CY1107206T1 (https=) |
| CZ (1) | CZ20033252A3 (https=) |
| DE (1) | DE60223805T2 (https=) |
| DK (1) | DK1399430T3 (https=) |
| ES (1) | ES2296965T3 (https=) |
| GB (1) | GB0113231D0 (https=) |
| HU (1) | HUP0400043A3 (https=) |
| IL (1) | IL158929A0 (https=) |
| MX (1) | MXPA03011032A (https=) |
| MY (1) | MY132656A (https=) |
| NO (1) | NO20035209L (https=) |
| NZ (1) | NZ529754A (https=) |
| PL (1) | PL367248A1 (https=) |
| PT (1) | PT1399430E (https=) |
| SI (1) | SI1399430T1 (https=) |
| TW (1) | TWI245760B (https=) |
| WO (1) | WO2002096895A1 (https=) |
| ZA (1) | ZA200309095B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04003398A (es) * | 2001-10-12 | 2004-11-22 | Nippon Chemiphar Co | Activador para el receptor o activado con el proliferador de peroxisoma. |
| AU2003261935A1 (en) | 2002-09-06 | 2004-03-29 | Takeda Pharmaceutical Company Limited | Furan or thiophene derivative and medicinal use thereof |
| GB0314370D0 (en) * | 2003-06-19 | 2003-07-23 | Glaxo Group Ltd | Chemical compounds |
| GB0323702D0 (en) * | 2003-10-09 | 2003-11-12 | Smithkline Beecham Corp | Chemical compound |
| CN1875002B (zh) | 2003-11-05 | 2011-08-03 | 霍夫曼-拉罗奇有限公司 | 作为ppar激动剂的苯基衍生物 |
| FR2882359A1 (fr) * | 2005-02-24 | 2006-08-25 | Negma Lerads Soc Par Actions S | Derives activateurs de ppar, procede de preparation et application en therapeutique |
| CN101007790B (zh) * | 2006-01-27 | 2011-03-30 | 北京摩力克科技有限公司 | 草氨酸衍生物、其制备方法和医药用途 |
| FR2901792A1 (fr) * | 2006-06-06 | 2007-12-07 | Negma Lerads Soc Par Actions S | DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE |
| CA2744985C (en) * | 2008-12-01 | 2014-05-06 | Mitsubishi Tanabe Pharma Corporation | Carboxylic acid derivative containing thiazole ring useful for the prevention or treatment of hyperlipidemia |
| CN110803996B (zh) * | 2019-11-13 | 2022-01-11 | 台州市创源工业技术有限公司 | 一种羟基苄胺的合成方法 |
| CN116511225B (zh) * | 2023-03-30 | 2025-09-23 | 江南大学 | 一种油酸基des液体及其制备方法和它在厌氧发酵液高效浓缩中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204277B1 (en) * | 1996-08-19 | 2001-03-20 | Japan Tobacco Inc. | Propionic acid derivatives and applications thereof |
| ATE451346T1 (de) | 1998-03-10 | 2009-12-15 | Ono Pharmaceutical Co | Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten |
| EP1177176B1 (en) * | 1999-04-28 | 2006-04-19 | Aventis Pharma Deutschland GmbH | Tri-aryl acid derivatives as ppar receptor ligands |
| GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| DE60005973T2 (de) * | 1999-08-27 | 2004-05-13 | Eli Lilly And Co., Indianapolis | Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren |
| PE20011010A1 (es) * | 1999-12-02 | 2001-10-18 | Glaxo Group Ltd | Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano |
| GB0113233D0 (en) * | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical compounds |
-
2001
- 2001-05-31 GB GBGB0113231.5A patent/GB0113231D0/en not_active Ceased
-
2002
- 2002-05-29 DE DE60223805T patent/DE60223805T2/de not_active Expired - Fee Related
- 2002-05-29 US US10/478,936 patent/US7157479B2/en not_active Expired - Fee Related
- 2002-05-29 AU AU2002317765A patent/AU2002317765B2/en not_active Ceased
- 2002-05-29 KR KR1020037015678A patent/KR100859591B1/ko not_active Expired - Fee Related
- 2002-05-29 PL PL02367248A patent/PL367248A1/xx not_active Application Discontinuation
- 2002-05-29 ES ES02747331T patent/ES2296965T3/es not_active Expired - Lifetime
- 2002-05-29 IL IL15892902A patent/IL158929A0/xx unknown
- 2002-05-29 EP EP02747331A patent/EP1399430B1/en not_active Expired - Lifetime
- 2002-05-29 BR BR0209785-0A patent/BR0209785A/pt not_active IP Right Cessation
- 2002-05-29 AR ARP020101999A patent/AR034051A1/es unknown
- 2002-05-29 SI SI200230654T patent/SI1399430T1/sl unknown
- 2002-05-29 PT PT02747331T patent/PT1399430E/pt unknown
- 2002-05-29 CN CNB028149424A patent/CN1307166C/zh not_active Expired - Fee Related
- 2002-05-29 NZ NZ529754A patent/NZ529754A/en unknown
- 2002-05-29 WO PCT/EP2002/005886 patent/WO2002096895A1/en not_active Ceased
- 2002-05-29 CZ CZ20033252A patent/CZ20033252A3/cs unknown
- 2002-05-29 JP JP2003500074A patent/JP2004532267A/ja active Pending
- 2002-05-29 MY MYPI20021973A patent/MY132656A/en unknown
- 2002-05-29 MX MXPA03011032A patent/MXPA03011032A/es active IP Right Grant
- 2002-05-29 CA CA002448205A patent/CA2448205A1/en not_active Abandoned
- 2002-05-29 HU HU0400043A patent/HUP0400043A3/hu unknown
- 2002-05-29 DK DK02747331T patent/DK1399430T3/da active
- 2002-05-29 TW TW091111392A patent/TWI245760B/zh not_active IP Right Cessation
-
2003
- 2003-11-21 ZA ZA200309095A patent/ZA200309095B/en unknown
- 2003-11-24 NO NO20035209A patent/NO20035209L/no not_active Application Discontinuation
- 2003-12-03 CO CO03106490A patent/CO5540297A2/es not_active Application Discontinuation
-
2008
- 2008-02-19 CY CY20081100202T patent/CY1107206T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0115109D0 (en) | Chemical compounds | |
| GB0103926D0 (en) | Chemical compounds | |
| GB0103630D0 (en) | Chemical compounds | |
| GB0115393D0 (en) | Chemical compounds | |
| GB0107228D0 (en) | Chemical compounds | |
| GB0127929D0 (en) | Chemical compounds | |
| AU2002366440A8 (en) | Chemical compounds | |
| GB0114005D0 (en) | Chemical compounds | |
| GB0108046D0 (en) | Chemical compounds | |
| GB0108793D0 (en) | Chemical compounds | |
| GB0108764D0 (en) | Chemical compounds | |
| GB0113231D0 (en) | Chemical compounds | |
| GB0106446D0 (en) | Chemical compounds | |
| GB0110797D0 (en) | Chemical compounds | |
| GB0101226D0 (en) | Chemical compounds | |
| GB0108594D0 (en) | Chemical compounds | |
| GB0104418D0 (en) | Chemical compounds | |
| GB0103628D0 (en) | Chemical compounds | |
| GB0106877D0 (en) | Chemical compounds | |
| GB0106871D0 (en) | Chemical compounds | |
| GB0108593D0 (en) | Chemical compounds | |
| GB0105077D0 (en) | Chemical Compounds | |
| GB0108654D0 (en) | Chemical compounds | |
| GB0103990D0 (en) | Chemical compounds | |
| GB0103629D0 (en) | Chemical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |